Filing Details
- Accession Number:
- 0000950170-25-010121
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-28 20:39:01
- Reporting Period:
- 2025-01-28
- Accepted Time:
- 2025-01-28 20:39:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1422143 | Kura Oncology Inc. | KURA | Pharmaceutical Preparations (2834) | 611547851 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2051106 | Mollie Leoni | C/O Kura Oncology, Inc. 12730 High Bluff Drive, Suite 400 San Diego CA 92130 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-01-28 | 2,253 | $7.87 | 90,963 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-01-28 | 1,353 | $7.87 | 89,610 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-01-28 | 816 | $7.87 | 88,794 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-01-28 | 541 | $7.87 | 88,253 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.
- Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
- Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.
- Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/21.